Abstract
The application of transgenesis has increased exponentially since its introduction in the early 1980s, and it is still one of the most powerful methods to study gene function. As approaches to solve scientific problems became more complex, transgene design evolved alongside. At this moment the versatility in strategies and applications of transgenic animal models is both staggering and exciting. An attempt to give a fully comprehensive overview of all variations in transgene design described in the scientific press would be an illusion and would exceed the aim of this chapter. Nevertheless, the strategy for generating a transgenic animal model (i.e., design of a transgene) warrants special attention to ensure the highest chances for success. Therefore, this chapter provides a concise overview of the elementary requirements of a transgenic construct and some considerations in transgene design. In addition, a number of aspects are discussed that may influence choices early on in the process of designing and generating a transgenic mouse model.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bates G. P., Mangiarini L., Mahal A., and Davies S. W. (1997) Transgenic models of Huntington’s disease. Hum. Mol. Genet. 6, 1633–1637.
Beal M. F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366, 211–223.
Gramolini A. O. and Jasmin B. J. (1997) Duchenne muscular dystrophy and the neuromuscular junction: the utrophin link. Bioessays 19, 747–750.
Erickson R. P. (1996) Mouse models of human genetic disease: which mouse is more like a man? Bioessays 18, 993–998.
Hsiao K. and Prusiner S. B. (1991) Molecular genetics and transgenic model of Gertsmann-Straussler-Scheinker disease. Alzheimer Dis. Assoc. Disord. 5, 155–162.
Leavitt B. R., Wellington C. L., and Hayden M. R. (1999) Recent insights into the molecular pathogenesis of Huntington disease. Semin. Neurol. 19, 385–95.
Mehler M. F. (2000) Brain dystrophin, neurogenetics and mental retardation. Brain Res. Brain Res. Rev. 32, 277–307.
Choi T., Huang M., Gorman C., and Jaenisch R. (1991) A generic intron increases gene expression in transgenic mice. Mol. Cell. Biol. 11, 3070–3074.
Aronow B. J., Silbiger R. N., Dusing M. R., et al. (1992) Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Mol. Cell. Biol. 12, 4170–4185.
Betz A. G., Milstein C., Gonzalez-Fernandez A., et al. (1994) Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell 77, 239–248.
Brooks A. R., Nagy B. P., Taylor S., et al. (1994) Sequences containing the second-intron enhancer are essential for transcription of the human apolipoprotein B gene in the livers of transgenic mice. Mol. Cell. Biol. 14, 2243–2256.
Charron G., Guy L. G., Bazinet M., and Julien J. P. (1995) Multiple neuronspecific enhancers in the gene coding for the human neurofilament light chain. J. Biol. Chem. 270, 30604–30610.
Dale T. C., Krnacik M. J., Schmidhauser C., et al. (1992) High-level expression of the rat whey acidic protein gene is mediated by elements in the promoter and 3′ untranslated region. Mol. Cell. Biol. 12, 905–914.
Krnacik M. J., Li S., Liao J., and Rosen J. M. (1995) Position-independent expression of whey acidic protein transgenes. J. Biol. Chem. 270, 11119–11129.
Li Q., Harju S., and Peterson K. R. (1999) Locus control regions: coming of age at a decade plus. Trends Genet. 15, 403–408.
Liska D. J., Reed M. J., Sage E. H., and Bornstein P. (1994) Cell-specific expression of alpha 1(I) collagen-hGH minigenes in transgenic mice. J. Cell Biol. 125, 695–704.
Zimmerman L., Parr B., Lendahl U., et al. (1994) Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 12, 11–24.
Kozak M. (1987) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196, 947–950.
Manson A. L., Trezise A. E., MacVinish L. J., et al. (1997) Complementation of null CF mice with a human CFTR YAC transgene. EMBO J. 16, 4238–4249.
Sun T., Jayatilake D., Afink G. B., et al. (2000) A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth. Development 127, 4519–4529.
Hodgson J. G., Agopyan N., Gutekunst C. A., et al. (1999) A YAC mouse model for Huntington’s disease with full-length mutant huntington, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23, 181–192.
Schedl A., Montoliu L., Kelsey G., and Schutz G. (1993) A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature 362, 258–261.
Vassaux G., Manson A. L., and Huxley C. (1997) Copy number-dependent expression of a YAC-cloned human CFTR gene in a human epithelial cell line. Gene Ther. 4, 618–623.
Palmiter R. D., Norstedt G., Gelinas R. E., et al. (1983) Metallothionein-human GH fusion genes stimulate growth of mice. Science 222, 809–814.
Palmiter R. D., Brinster R. L., Hammer R. E., et al. (1982) Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300, 611–615.
Brinster R. L. and Palmiter R. D. (1984) Transgenic mice containing growth hormone fusion genes. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 307, 309–312.
Brinster R. L., Chen H. Y., Trumbauer M., et al. (1981) Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 27, 223–31.
Palmiter R. D., Wilkie T. M., Chen H. Y., and Brinster R. L. (1984) Transmission distortion and mosaicism in an unusual transgenic mouse pedigree. Cell 36, 869–77.
Ghoshal K. and Jacob S. T. (2000) Regulation of metallothionein gene expression. Prog. Nucleic Acid Res. Mol. Biol. 66, 357–384.
Fishman G. I. (1998) Timing is everything in life: conditional transgene expression in the cardiovascular system. Circ. Res. 82, 837–844.
Chin L. and DePinho R. A. (2000) Flipping the oncogene switch: illumination of tumor maintenance and regression. Trends Genet. 16, 147–50.
Gardner D. P., Byrne G. W., Ruddle F. H., and Kappen C. (1996) Spatial and temporal regulation of a lacZ reporter transgene in a binary transgenic mouse system. Transgenic Res. 5, 37–48.
Furth P. A., St Onge L., Boger H., et al. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302–9306.
Jaisser F. (2000) Inducible gene expression and gene modification in transgenic mice. J. Am. Soc. Nephrol. 11(Suppl 16), S95–S100.
St-Onge L., Furth P. A., and Gruss P. (1996) Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 24, 3875–3877.
Shockett P., Difilippantonio M., Hellman N., and Schatz D. G. (1995) A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92, 6522–6526.
Zhao B., Magdaleno S., Chua S., et al. (2000) Transgenic mouse models for lung cancer. Exp. Lung Res. 26, 567–579.
Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning. A Laboratory Manual, 2nd ed. (Ford N., ed.), Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY.
Heisterkamp N., Groffen J., and Stephenson J. R. (1983) The human v-abl cellular homologue. J. Mol. Appl. Genet. 2, 57–68.
Scrable H. and Stambrook P. J. (1999) A genetic program for deletion of foreign DNA from the mammalian genome. Mutat. Res. 429, 225–237.
Doerfler W. (1991) Patterns of DNA methylation—evolutionary vestiges of foreign DNA inactivation as a host defense mechanism. A proposal. Biol. Chem. Hoppe Seyler 372, 557–564.
Clark A. J., Harold G., and Yull F. E. (1997) Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice. Nucleic Acids Res. 25, 1009–1014.
Martin D. I. and Whitelaw E. (1996) The vagaries of variegating transgenes. Bioessays 18, 919–923.
Henikoff S. (1998) Conspiracy of silence among repeated transgenes. Bioessays 20, 532–535.
Garrick D., Fiering S., Martin D. I., and Whitelaw E. (1998) Repeat-induced gene silencing in mammals. Nat. Genet. 18, 56–59.
Heisterkamp N., Jenster G., ten Hoeve J., et al. (1990) Acute leukaemia in bcr/abl transgenic mice. Nature 344, 251–253.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Willem Voncken, J. (2003). Transgene Design. In: Hofker, M.H., van Deursen, J. (eds) Transgenic Mouse. Methods in Molecular Biology™, vol 209. Humana Press. https://doi.org/10.1385/1-59259-340-2:51
Download citation
DOI: https://doi.org/10.1385/1-59259-340-2:51
Publisher Name: Humana Press
Print ISBN: 978-0-89603-915-5
Online ISBN: 978-1-59259-340-8
eBook Packages: Springer Protocols